RhumbLine Advisers’s Advanced Health Intelligence Ltd AHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$847 Hold
565
﹤0.01% 3990
2025
Q4
$847 Hold
565
﹤0.01% 4036
2025
Q3
$847 Sell
565
-1,400
-71% -$2.1K ﹤0.01% 4032
2025
Q2
$2.95K Hold
1,965
﹤0.01% 3963
2025
Q1
$2.95K Hold
1,965
﹤0.01% 3951
2024
Q4
$2.95K Hold
1,965
﹤0.01% 4006
2024
Q3
$2.95K Hold
1,965
﹤0.01% 4034
2024
Q2
$2.95K Hold
1,965
﹤0.01% 4152
2024
Q1
$2.95K Hold
1,965
﹤0.01% 4047
2023
Q4
$4.3K Buy
1,965
+1,335
+212% +$2.73K ﹤0.01% 4009
2023
Q3
$1.57K Buy
+630
New +$2.38K ﹤0.01% 4137

RhumbLine Advisers's AHI Position: Q1 2026 in Review

RhumbLine Advisers held its Advanced Health Intelligence Ltd (AHI) position steady in Q1 2026 at 565 shares worth $847. The position accounts for ﹤0.01% of the portfolio, ranked #3990.

RhumbLine Advisers first reported a position in AHI in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.3K in Q4 2023. 1 fund tracked by Wall St. Rank holds AHI as of Q1 2026.

  • RhumbLine Advisers held 565 shares of Advanced Health Intelligence Ltd worth $847 as of Q1 2026.
  • RhumbLine Advisers left its Advanced Health Intelligence Ltd share count unchanged in Q1 2026.
  • Advanced Health Intelligence Ltd made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #3990 holding.
  • RhumbLine Advisers first reported a position in Advanced Health Intelligence Ltd in Q3 2023 and has held it in 11 quarters since.
  • RhumbLine Advisers's Advanced Health Intelligence Ltd position peaked at $4.3K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Advanced Health Intelligence Ltd as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.